Raymond N. DuBois, MD, PhD, is the director of the Hollings Cancer Center at the Medical University of South Carolina in Charleston, SC, and the Executive Chair of the Board of the Mark Foundation for Cancer Research. Previously, he was executive director of the Biodesign Institute at Arizona State University with a joint clinical appointment at the Mayo Clinic. He has also served as provost and executive vice president at the University of Texas MD Anderson Cancer Center, and director of the Vanderbilt-Ingram Cancer Center.
Dr. DuBois earned his bachelor’s degree from Texas A&M University, and a doctoral degree from the UT Southwestern Medical Center in Dallas. He then went on to obtain his medical degree from the UT Health Science Center in San Antonio. He continued his training, particularly in gastroenterology, at the Johns Hopkins Hospital in Baltimore.
Dr. DuBois served as the AACR president in 2008. Aside from being a Fellow of the AACR Academy, he is an AAAS Fellow and has been elected to the American Society for Clinical Investigation. He is a renowned expert on the molecular and genetic basis for colorectal cancer. One of his seminal discoveries was on the role of COX2 in colon cancer. This led to the use of a COX-2 inhibitor in reducing polyp formation in patients with familial adenomatous polyposis.